OSTEOPOROSIS: A VIEW OF THE PROBLEM OF DIAGNOSIS AND TREATMENT

Abstract

The incidence of osteoporosis (OP) has steadily increased in the past decades. Its official morbidity registration has been initiated in the Russian Federation since 1999. There has been a more than 3-fold rise in the total notified cases of OP among Russia's adults in the past 10 years; however, these figures are not true since patients frequently seek medical advice for the OP complications - fractures. The medications that affect different mechanisms of the disease are now of priority in the treatment of OP. Biphosphonates have occupied a prominent place in the treatment and prevention of OP over the past decade. A combination of alendronate and vitamin D3 in the same tablet is a step forward in the therapy of OP since, in addition to its pathogenetic treatment, it additionally provides the organism with vitamin D3.